Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
9.31
+0.23 (2.53%)
At close: Nov 21, 2024, 4:00 PM
9.10
-0.21 (-2.26%)
After-hours: Nov 21, 2024, 5:16 PM EST
Enanta Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 |
| Net Income | -115.33 | -133.82 | -121.76 | -79 | -36.17 | 46.38 | |
| Depreciation & Amortization | 2.53 | 2.37 | 2.97 | 3.33 | 3.64 | 3.26 | |
| Loss (Gain) From Sale of Assets | 0.14 | 0.15 | - | - | - | - | |
| Loss (Gain) From Sale of Investments | - | -2.93 | 0.33 | -1.91 | -3.27 | -5.83 | |
| Stock-Based Compensation | 25.79 | 28.22 | 26.97 | 20.99 | 19.58 | 19.23 | |
| Other Operating Activities | -7.27 | -5.17 | -0.08 | 0.28 | 10.41 | -3.11 | |
| Change in Accounts Receivable | 10.72 | 11.7 | 3.26 | -0.08 | 27.82 | 15.89 | |
| Change in Accounts Payable | -2.71 | -1.15 | -4.63 | 3.77 | -0.88 | 1.79 | |
| Change in Income Taxes | -6.54 | -2.29 | 8.54 | -24.21 | -4.13 | -10.3 | |
| Change in Other Net Operating Assets | 2.71 | -0.24 | -0.37 | 6.84 | -9.91 | 4.11 | |
| Operating Cash Flow | -89.97 | -103.15 | -84.78 | -70 | 7.09 | 71.42 | |
| Operating Cash Flow Growth | - | - | - | - | -90.08% | 144.41% | |
| Capital Expenditures | -10.37 | -9.06 | -2.13 | -0.75 | -1.45 | -5.42 | |
| Investment in Securities | 61.36 | -44.52 | 57.02 | 37.74 | 21.28 | -81.25 | |
| Investing Cash Flow | 51 | -53.58 | 54.9 | 36.99 | 19.83 | -86.66 | |
| Long-Term Debt Repaid | - | - | - | - | - | -0.09 | |
| Net Debt Issued (Repaid) | - | - | - | - | - | -0.09 | |
| Issuance of Common Stock | 0.08 | 2.21 | 21.26 | 3.61 | 10.48 | 6.85 | |
| Repurchase of Common Stock | - | - | - | - | - | -4.19 | |
| Other Financing Activities | -20.51 | 195.92 | -1.23 | -0.53 | -1.5 | - | |
| Financing Cash Flow | -20.43 | 198.13 | 20.03 | 3.08 | 8.98 | 2.57 | |
| Net Cash Flow | -59.4 | 41.39 | -9.85 | -29.93 | 35.9 | -12.67 | |
| Free Cash Flow | -100.33 | -112.21 | -86.91 | -70.75 | 5.64 | 66 | |
| Free Cash Flow Growth | - | - | - | - | -91.45% | 151.54% | |
| Free Cash Flow Margin | -139.43% | -141.67% | -100.87% | -72.88% | 4.61% | 32.16% | |
| Free Cash Flow Per Share | -4.75 | -5.35 | -4.22 | -3.51 | 0.28 | 3.15 | |
| Cash Income Tax Paid | 4.9 | 4.9 | - | 0.03 | 0.11 | 12.67 | |
| Levered Free Cash Flow | -63.27 | -62.34 | -42.08 | -57.67 | 9.55 | 51.65 | |
| Unlevered Free Cash Flow | -56.08 | -59.13 | -42.08 | -57.67 | 9.55 | 51.65 | |
| Change in Net Working Capital | -2.76 | -5.1 | -7.51 | 12.76 | -13.8 | -11.62 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.